Class Cert. Denied Again In Gout Drug Antitrust Case
By Matthew Perlman · March 1, 2023, 6:30 PM EST
A Pennsylvania federal court has again refused to certify a class of drug wholesalers accusing Takeda Pharmaceuticals and others of delaying generic competition for the anti-gout drug Colcrys, finding that it...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login